Chronic Pelvic Pain SyndromeNCT07328672
Pain Neuroscience Education and Basic Body Awareness Therapy in Women With Chronic Pelvic Pain
A study testing Standard Physiotherapy and Rehabilitation, Pain Neuroscience Education and Basic Body Awareness Therapy in people with Chronic Pelvic Pain Syndrome and Female, run by Sena Öndeş.
Trial summary
This randomized controlled trial aims to investigate the effects of Pain Neuroscience Education and Basic Body Awareness Therapy, when added to standard physiotherapy and rehabilitation, on pain, autonomic nervous system responses, and pelvic floor muscle activity in women with chronic pelvic pain. Read more about this study
- Who is it for?
- Ages 20 to 65 years, women only
- Conditions the study is for
- Chronic Pelvic Pain Syndrome, Female
- What is being tested?
- Standard Physiotherapy and Rehabilitation, Pain Neuroscience Education and Basic Body Awareness Therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- No sites listed yet
- Study dates
- 15 Jan 2026to 15 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Women with any type of chronic pelvic pain, including pelvic floor muscle dysfunction, endometriosis, vulvodynia, genito-pelvic pain/penetration disorder, or bladder pain syndrome, with pain persisting for six months or longer.
Who cannot join
- Presence of pelvic infections, inflammatory conditions, or pelvic malignancy.
- Pregnancy.
- History of urogynecological surgery within the last six months.
- Presence of advanced pelvic organ prolapse.
- Patients currently receiving chemotherapy or radiotherapy.
- Patients whose primary complaint is not chronic pelvic pain.
About this study
Official title: Investigation of the Effects of Pain Neuroscience Education and Basic Body Awareness Therapy on Pain, Autonomic Nervous System Responses, and Pelvic Floor Muscle Activity in Women With Chronic Pelvic Pain
This randomized controlled trial aims to investigate the effects of Pain Neuroscience Education and Basic Body Awareness Therapy, when added to standard physiotherapy and rehabilitation, on pain, autonomic nervous system responses, and pelvic floor muscle activity in women with chronic pelvic pain. A total of 45 women diagnosed with chronic pelvic pain will be randomly allocated into three groups: (1) standard physiotherapy and rehabilitation, (2) standard physiotherapy plus Pain Neuroscience Education, and (3) standard physiotherapy plus Basic Body Awareness Therapy. The study will assess pain intensity (algometry, NRS, SF-MPQ), pain catastrophizing, autonomic responses (electrodermal activity), pelvic floor muscle activation (EMG), and related psychological, cognitive, and body awareness parameters. Secondary outcomes will include sexual function, quality of life, and patient satisfaction. The aim is to compare two awareness-based interventions-one primarily mind-to-body (Pain Neuroscience Education) and the other body-to-mind (Basic Body Awareness Therapy)-to determine their relative and complementary effects on pain perception and physiological regulation in women with chronic pelvic pain.
- Conditions
- Chronic Pelvic Pain Syndrome, Female
- Being tested
- Standard Physiotherapy and Rehabilitation, Pain Neuroscience Education, Basic Body Awareness Therapy
- Keywords
- Body Awareness, Basic Body Awareness Therapy, Pelvic Floor Muscle Activity, Autonomic Nervous System, Physiotherapy, Rehabilitation, Chronic Pelvic Pain, Pelvic Floor Muscles, Pain Neuroscience Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard Physiotherapy and RehabilitationBehavioural
The interventions will be conducted over 8 weeks, with sessions held twice per week.
The Standard Physiotherapy and Rehabilitation program includes pelvic floor muscle relaxation, myofascial release, stretching, breathing and relaxation exercises, and aerobic training.
Pain Neuroscience EducationBehavioural
The Pain Neuroscience Education (PNE) group will receive the same physiotherapy program plus weekly educational sessions focused on pain neurophysiology, central sensitization, and cognitive reframing strategies, delivered by a physiotherapist trained in Pain Neuroscience Education.
Basic Body Awareness TherapyBehavioural
The Basic Body Awareness Therapy (BBAT) group will receive the same physiotherapy program plus weekly body awareness sessions emphasizing postural alignment, movement control and breathing. Exercises will be practiced in supine, sitting, and standing positions to enhance body-mind awareness.
All interventions will be supervised by an experienced pelvic floor physiotherapist at Istinye University.
| Study group | Role | What they receive |
|---|---|---|
| Pain Neuroscience Education + Standard Physiotherapy and Rehabilitation | Experimental | Participants receive the standard physiotherapy and rehabilitation program in addition to structured Pain Neuroscience Education sessions. Receives: Behavioral: Standard Physiotherapy and Rehabilitation; Behavioral: Pain Neuroscience Education |
| Basic Body Awareness Therapy + Standard Physiotherapy Group | Experimental | Participants receive the standard physiotherapy and rehabilitation program in addition to Basic Body Awareness Therapy sessions focusing on posture, movement and breathing. Receives: Behavioral: Standard Physiotherapy and Rehabilitation; Behavioral: Basic Body Awareness Therapy |
| Standard Physiotherapy and Rehabilitation Group | Active comparator | Participants receive standard pelvic physiotherapy and rehabilitation interventions, including relaxation training, myofascial release, stretching, breathing, and aerobic exercises. Receives: Behavioral: Standard Physiotherapy and Rehabilitation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pressure Pain Threshold and Pain Tolerance
Pressure pain threshold and tolerance will be assessed using a Baseline® manual algometer. Standardized measurement points will be located in the abdominal and pelvic regions (15 points in total). Pressure will be applied perpendicularly at a rate of 1 kg/s until the participant reports the first pain sensation and maximum tolerable pain. The mean of two measurements per site will be used for analysis. Distal control points (C5-C6 zygapophyseal level, second metacarpal, and tibialis anterior muscle) will be included to evaluate widespread pressure sensitivity as an indicator of central sensitization.
Measured: Baseline and up to 8 weeks
Pain Intensity and Characteristics (Short Form McGill Pain Questionnaire)
Pain intensity and characteristics will be assessed using the Short Form McGill Pain Questionnaire (SF-MPQ). The SF-MPQ evaluates both sensory (11 items) and affective (4 items) dimensions of pain through 15 descriptors rated on a 4-point scale (0 = none to 3 = severe). It also includes a Visual Analog Scale (VAS) and a 6-point Likert scale assessing overall pain intensity (0 = no pain to 5 = unbearable pain). Total scores will be calculated for sensory, affective, and overall dimensions.
Measured: Baseline and up to 8 weeks
Pain Catastrophizing (Pain Catastrophizing Scale)
Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS), a 13-item self-report questionnaire developed by Sullivan et al. to measure negative cognitive and emotional responses to pain. Each item is rated on a 5-point Likert scale (0 = not at all, 4 = all the time), with total scores ranging from 0 to 52. Higher scores indicate greater levels of catastrophizing. The PCS includes three subscales: rumination, magnification, and helplessness.
Measured: Baseline and up to 8 weeks
Autonomic Nervous System Responses - Tonic Skin Conductance Level (SCL)
Resting tonic skin conductance level will be recorded using the Shimmer3 GSR+ device with electrodes placed on the hypothenar region. Higher SCL indicates increased sympathetic arousal.
Measured: Baseline and up to 8 weeks
Autonomic Nervous System Responses- Phasic Skin Conductance Response (SCR) Amplitude
Phasic SCR amplitude will be recorded during painful pressure stimuli applied at the Pfannenstiel incision point. This parameter reflects rapid sympathetic responses to pain.
Measured: Baseline and up to 8 weeks
Autonomic Nervous System Responses- Skin Conductance Response Frequency
The total number of phasic responses during the stimulus period will be counted to quantify response frequency.
Measured: Baseline and up to 8 weeks
Autonomic Nervous System Responses- Skin Conductance Response Latency
Latency from stimulus onset to the first SCR will be measured to assess autonomic response timing.
Measured: Baseline and up to 8 weeks
Resting Pelvic Floor Muscle Activity (Resting sEMG) (Surface Electromyography)
Resting pelvic floor muscle activity will be recorded using surface electromyography (NeuroTrac® MyoPlus PRO). Electrodes will be placed bilaterally in the perianal region. Mean resting µV value across trials will be used for analysis.
Measured: Baseline and up to 8 weeks
Minimum Pelvic Floor Muscle Activation (Minimum sEMG) (Surface Electromyography)
Minimum muscle activation during contraction attempts will be recorded in µV. The lowest activation value across the contraction-relaxation cycles will be used.
Measured: Baseline and up to 8 weeks
Maximum Voluntary Contraction of Pelvic Floor Muscles (MVC) (Surface Electromyography)
MVC will be assessed during five maximal pelvic floor contractions. Values will be expressed as percent activation relative to baseline.
Measured: Baseline and up to 8 weeks
Pelvic Floor Muscle Relaxation Time (Surface Electromyography)
Relaxation time will be measured as the time required for sEMG amplitude to return from peak activation to baseline following a contraction.
Measured: Baseline and up to 8 weeks
Secondary outcomes (8)
Pain-Related Beliefs (Pain Beliefs Questionnaire)
Pain-related cognitive beliefs will be assessed using the Pain Beliefs Questionnaire (PBQ), which evaluates individuals' beliefs about the causes, meaning, and controllability of pain. The PBQ consists of two subscales: organic beliefs (the idea that pain indicates tissue damage) and psychological beliefs (the idea that pain is influenced by emotional and mental processes). Each item is rated on a 6-point Likert scale (1 = never, 6 = always), with higher scores indicating stronger beliefs in each domain. The questionnaire will be used to assess changes in pain-related cognitions and cognitive restructuring following the interventions.
Measured: Baseline and up to 8 weeks
Pelvic Floor Symptoms (Global Pelvic Floor Bother Questionnaire)
Pelvic floor dysfunction-related symptoms will be assessed using the Global Pelvic Floor Bother Questionnaire (PFBQ). This questionnaire evaluates the severity of pelvic floor symptoms and their impact on daily life, including stress urinary incontinence, urinary frequency, urgency, urge incontinence, voiding difficulty, pelvic organ prolapse, obstructive defecation, fecal incontinence, and dyspareunia. Each symptom is answered as "Yes/No," and if "Yes," participants rate the bother level from 1 (not at all) to 5 (a lot). The total score ranges from 0 to 45, with higher scores indicating greater symptom severity or bother.
Measured: Baseline and up to 8 weeks
Female Sexual Function (Female Sexual Function Index)
Female sexual function will be assessed using the Female Sexual Function Index (FSFI), a validated, multidimensional questionnaire developed by Rosen et al. It consists of 19 items rated on a 5-point Likert scale and evaluates six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. Total scores range from 2.0 to 36.0, with higher scores indicating better sexual function. A cutoff score of 26.55 differentiates between normal and dysfunctional sexual function.
Measured: Baseline and up to 8 weeks
Depression, Anxiety, and Stress Levels (Depression Anxiety Stress Scale-21)
Depression, anxiety, and stress levels will be assessed using the Depression Anxiety Stress Scale-21 (DASS-21), a reliable 21-item self-report questionnaire developed by Lovibond \& Lovibond and validated in Turkish by Yılmaz et al. (2017). The scale includes three subscales-depression, anxiety, and stress-each with seven items rated on a 4-point Likert scale (0 = did not apply to me at all to 3 = applied to me very much). Higher scores indicate greater emotional distress. Severity for each subscale is categorized as normal, mild, moderate, severe, or extremely severe.
Measured: Baseline and up to 8 weeks
Interoceptive Awareness (Multidimensional Assessment of Interoceptive Awareness II)
Interoceptive awareness will be evaluated using the Multidimensional Assessment of Interoceptive Awareness II (MAIA-II), developed by Mehling et al. (2018) and validated in Turkish by Özpınar et al. (2021). The MAIA-II consists of 37 items rated on a 6-point Likert scale (0 = never to 5 = always) and measures eight dimensions of interoceptive awareness, including noticing, attention regulation, emotional awareness, self-regulation, and body trust. Higher scores indicate greater interoceptive awareness. Negatively worded items (items 5-12 and 15) are reverse-scored before subscale means are calculated.
Measured: Baseline and up to 8 weeks
Quality of Life (WHOQOL-BREF)
Quality of life will be evaluated using the World Health Organization Quality of Life Scale-Short Form (WHOQOL-BREF) and the Pelvic Pain Impact Questionnaire (PIQ). The WHOQOL-BREF, validated in Turkish by Eser et al. (1999), consists of 27 items rated on a 5-point Likert scale and assesses four domains: physical, psychological, social, and environmental. Higher scores indicate better quality of life.
Measured: Baseline and up to 8 weeks
Quality of Life (Pelvic Pain Impact Questionnaire)
The PIQ, developed by Chalmers et al. (2017) and validated in Turkish by Kurt et al. (2023), is an 8-item Likert-type scale assessing the multidimensional impact of chronic pelvic pain on energy, mood, sleep, gastrointestinal function, sitting tolerance, daily activities, physical activity, and clothing. Two additional open-ended questions address sexual activity and tampon use but are not included in the total score. Higher scores reflect greater impact of pain on daily life.
Measured: Baseline and up to 8 weeks
Patient Satisfaction (Numeric Rating Scale)
Patient satisfaction with the treatment will be assessed using a Numeric Rating Scale (NRS). Participants will be asked to rate their overall satisfaction with the treatment on a scale from 0 to 10, where 0 indicates "not satisfied at all" and 10 indicates "completely satisfied." Higher scores reflect greater satisfaction. This subjective self-assessment will be conducted at the end of the 8-week intervention period.
Measured: After 8 weeks of intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jan 2026
- Study start15 Jan 2026 (estimated)
- Primary completion15 Oct 2026 (estimated)
- Study completion15 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic Pelvic Pain SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 45 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sena Öndeş
- Sponsor type
- University, hospital or other
- Collaborators
- Istinye University
- Responsible party
- Sponsor-investigator, Sena Öndeş, Atlas University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07328672
- Sponsor's protocol ID
- DrThesis
- Status last verified
- Dec 2025
- First submitted
- 25 Nov 2025
- Last updated
- 9 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Effects of Pain Neuroscience Education and Basic Body Awareness Therapy on Pain, Autonomic Nervous System Responses, and Pelvic Floor Muscle Activity in Women With Chronic Pelvic Pain
- ClinicalTrials.gov ID
- NCT07328672
- Acronym / sponsor ID
- DrThesis
- Conditions
- Chronic Pelvic Pain Syndrome, Female
- Keywords
- Body Awareness, Basic Body Awareness Therapy, Pelvic Floor Muscle Activity, Autonomic Nervous System, Physiotherapy, Rehabilitation, Chronic Pelvic Pain, Pelvic Floor Muscles
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 45 participants (estimated)
- Lead sponsor
- Sena ÖndeşUniversity, hospital or other
- Collaborators
- Istinye University
- Study start
- 15 Jan 2026 (estimated)
- Primary completion
- 15 Oct 2026 (estimated)
- Study completion
- 15 Dec 2026 (estimated)
- First posted
- 9 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial aims to investigate the effects of Pain Neuroscience Education and Basic Body Awareness Therapy, when added to standard physiotherapy and rehabilitation, on pain, autonomic nervous system responses, and pelvic floor muscle activity in women with chronic pelvic pain. A total of 45 women diagnosed with chronic pelvic pain will be randomly allocated into three groups: (1) standard physiotherapy and rehabilitation, (2) standard physiotherapy plus Pain Neuroscience Education, and (3) standard physiotherapy plus Basic Body Awareness Therapy. The study will assess pain intensity (algometry, NRS, SF-MPQ), pain catastrophizing, autonomic responses (electrodermal activity), pelvic floor muscle activation (EMG), and related psychological, cognitive, and body awareness parameters. Secondary outcomes will include sexual function, quality of life, and patient satisfaction. The aim is to compare two awareness-based interventions-one primarily mind-to-body (Pain Neuroscience Education) and the other body-to-mind (Basic Body Awareness Therapy)-to determine their relative and complementary effects on pain perception and physiological regulation in women with chronic pelvic pain.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Pain Neuroscience Education + Standard Physiotherapy and Rehabilitation | Experimental | Behavioral: Standard Physiotherapy and Rehabilitation, Behavioral: Pain Neuroscience EducationParticipants receive the standard physiotherapy and rehabilitation program in addition to structured Pain Neuroscience Education sessions. |
| Basic Body Awareness Therapy + Standard Physiotherapy Group | Experimental | Behavioral: Standard Physiotherapy and Rehabilitation, Behavioral: Basic Body Awareness TherapyParticipants receive the standard physiotherapy and rehabilitation program in addition to Basic Body Awareness Therapy sessions focusing on posture, movement and breathing. |
| Standard Physiotherapy and Rehabilitation Group | Active comparator | Behavioral: Standard Physiotherapy and RehabilitationParticipants receive standard pelvic physiotherapy and rehabilitation interventions, including relaxation training, myofascial release, stretching, breathing, and aerobic exercises. |
Who may qualify
- Ages
- 20 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Women with any type of chronic pelvic pain, including pelvic floor muscle dysfunction, endometriosis, vulvodynia, genito-pelvic pain/penetration disorder, or bladder pain syndrome, with pain persisting for six months or longer.
Key exclusion criteria (6 listed)
- Presence of pelvic infections, inflammatory conditions, or pelvic malignancy.
- Pregnancy.
- History of urogynecological surgery within the last six months.
- Presence of advanced pelvic organ prolapse.
- Patients currently receiving chemotherapy or radiotherapy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard Physiotherapy and RehabilitationThe interventions will be conducted over 8 weeks, with sessions held twice per week. The Standard Physiotherapy and Rehabilitation program includes pelvic floor muscle relaxation, myofascial release, stretching, breathing and relaxation exercises, and aerobic training. | Behavioural | Basic Body Awareness Therapy + Standard Physiotherapy Group, Pain Neuroscience Education + Standard Physiotherapy and Rehabilitation, Standard Physiotherapy and Rehabilitation Group |
| Pain Neuroscience EducationThe Pain Neuroscience Education (PNE) group will receive the same physiotherapy program plus weekly educational sessions focused on pain neurophysiology, central sensitization, and cognitive reframing strategies, delivered by a physiotherapist trained in Pain Neuroscience Education. | Behavioural | Pain Neuroscience Education + Standard Physiotherapy and Rehabilitation |
| Basic Body Awareness TherapyThe Basic Body Awareness Therapy (BBAT) group will receive the same physiotherapy program plus weekly body awareness sessions emphasizing postural alignment, movement control and breathing. Exercises will be practiced in supine, sitting, and standing positions to enhance body-mind awareness. All interventions will be supervised by an experienced pelvic floor physiotherapist at Istinye University. | Behavioural | Basic Body Awareness Therapy + Standard Physiotherapy Group |
Primary outcome
Pressure Pain Threshold and Pain Tolerance
Time frame: Baseline and up to 8 weeks
Pressure pain threshold and tolerance will be assessed using a Baseline® manual algometer. Standardized measurement points will be located in the abdominal and pelvic regions (15 points in total). Pressure will be applied perpendicularly at a rate of 1 kg/s until the participant reports the first pain sensation and maximum tolerable pain. The mean of two measurements per site will be used for analysis. Distal control points (C5-C6 zygapophyseal level, second metacarpal, and tibialis anterior muscle) will be included to evaluate widespread pressure sensitivity as an indicator of central sensitization.
Pain Intensity and Characteristics (Short Form McGill Pain Questionnaire)
Time frame: Baseline and up to 8 weeks
Pain intensity and characteristics will be assessed using the Short Form McGill Pain Questionnaire (SF-MPQ). The SF-MPQ evaluates both sensory (11 items) and affective (4 items) dimensions of pain through 15 descriptors rated on a 4-point scale (0 = none to 3 = severe). It also includes a Visual Analog Scale (VAS) and a 6-point Likert scale assessing overall pain intensity (0 = no pain to 5 = unbearable pain). Total scores will be calculated for sensory, affective, and overall dimensions.
Pain Catastrophizing (Pain Catastrophizing Scale)
Time frame: Baseline and up to 8 weeks
Pain catastrophizing will be assessed using the Pain Catastrophizing Scale (PCS), a 13-item self-report questionnaire developed by Sullivan et al. to measure negative cognitive and emotional responses to pain. Each item is rated on a 5-point Likert scale (0 = not at all, 4 = all the time), with total scores ranging from 0 to 52. Higher scores indicate greater levels of catastrophizing. The PCS includes three subscales: rumination, magnification, and helplessness.
Autonomic Nervous System Responses - Tonic Skin Conductance Level (SCL)
Time frame: Baseline and up to 8 weeks
Resting tonic skin conductance level will be recorded using the Shimmer3 GSR+ device with electrodes placed on the hypothenar region. Higher SCL indicates increased sympathetic arousal.
Autonomic Nervous System Responses- Phasic Skin Conductance Response (SCR) Amplitude
Time frame: Baseline and up to 8 weeks
Phasic SCR amplitude will be recorded during painful pressure stimuli applied at the Pfannenstiel incision point. This parameter reflects rapid sympathetic responses to pain.
Autonomic Nervous System Responses- Skin Conductance Response Frequency
Time frame: Baseline and up to 8 weeks
The total number of phasic responses during the stimulus period will be counted to quantify response frequency.
Autonomic Nervous System Responses- Skin Conductance Response Latency
Time frame: Baseline and up to 8 weeks
Latency from stimulus onset to the first SCR will be measured to assess autonomic response timing.
Resting Pelvic Floor Muscle Activity (Resting sEMG) (Surface Electromyography)
Time frame: Baseline and up to 8 weeks
Resting pelvic floor muscle activity will be recorded using surface electromyography (NeuroTrac® MyoPlus PRO). Electrodes will be placed bilaterally in the perianal region. Mean resting µV value across trials will be used for analysis.
Minimum Pelvic Floor Muscle Activation (Minimum sEMG) (Surface Electromyography)
Time frame: Baseline and up to 8 weeks
Minimum muscle activation during contraction attempts will be recorded in µV. The lowest activation value across the contraction-relaxation cycles will be used.
Maximum Voluntary Contraction of Pelvic Floor Muscles (MVC) (Surface Electromyography)
Time frame: Baseline and up to 8 weeks
MVC will be assessed during five maximal pelvic floor contractions. Values will be expressed as percent activation relative to baseline.
Pelvic Floor Muscle Relaxation Time (Surface Electromyography)
Time frame: Baseline and up to 8 weeks
Relaxation time will be measured as the time required for sEMG amplitude to return from peak activation to baseline following a contraction.
8 secondary outcomes
Pain-Related Beliefs (Pain Beliefs Questionnaire)
Time frame: Baseline and up to 8 weeks
Pelvic Floor Symptoms (Global Pelvic Floor Bother Questionnaire)
Time frame: Baseline and up to 8 weeks
Female Sexual Function (Female Sexual Function Index)
Time frame: Baseline and up to 8 weeks
Depression, Anxiety, and Stress Levels (Depression Anxiety Stress Scale-21)
Time frame: Baseline and up to 8 weeks
Interoceptive Awareness (Multidimensional Assessment of Interoceptive Awareness II)
Time frame: Baseline and up to 8 weeks
Quality of Life (WHOQOL-BREF)
Time frame: Baseline and up to 8 weeks
Quality of Life (Pelvic Pain Impact Questionnaire)
Time frame: Baseline and up to 8 weeks
Patient Satisfaction (Numeric Rating Scale)
Time frame: After 8 weeks of intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jan 2026.
Related trials for Chronic Pelvic Pain Syndrome
Not yet recruiting
Focused Ultrasound Neuromodulation for Chronic Pain
Chronic Pain, Sickle Cell Disease
Not yet recruiting
Pregabalin for Chronic Pelvic Pain in Women
Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome
Recruiting
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
Chronic Pelvic Pain Syndrome, Pelvic Pain
Recruiting
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
Urologic Chronic Pelvic Pain Syndrome (UCPPS), Interstitial Cystitis
Enrolling by invitation
Pulsed Electromagnetic Versus Hydrotherapy on Chronic Pelvic Pain
Chronic Pelvic Pain Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Standard Physiotherapy and Rehabilitation, Pain Neuroscience Education and Basic Body Awareness Therapy in people with Chronic Pelvic Pain Syndrome and Female, run by Sena Öndeş.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pressure Pain Threshold and Pain Tolerance (time frame: Baseline and up to 8 weeks). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2026.